| Differences in warfarin dosing decisions based on international normalized ratio measurements with two point‐of‐care testing devices and a reference laboratory measurement KM Shermock, L Bragg, JT Connor, J Fink, G Mazzoli, K Kottke‐Marchant Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 22 (11 …, 2002 | 3216 | 2002 |
| Gastroenterologist-administered propofol versus meperidine and midazolam for advanced upper endoscopy: a prospective, randomized trial JJ Vargo, G Zuccaro Jr, JA Dumot, JB Morrow, DL Conwell, PA Trolli, ... Gastroenterology 123 (1), 8-16, 2002 | 424 | 2002 |
| Cost effectiveness of interferon α2b combined with ribavirin for the treatment of chronic hepatitis C ZM Younossi, ME Singer, JG McHutchison, KM Shermock Hepatology 30 (5), 1318-1324, 1999 | 211 | 1999 |
| Implementation and pharmacoeconomic analysis of a clinical staff pharmacist practice model TW Nesbit, KM Shermock, MB Bobek, DL Capozzi, PA Flores, ... American journal of health-system pharmacy 58 (9), 784-790, 2001 | 181 | 2001 |
| The effectiveness of prophylactic inferior vena cava filters in trauma patients: a systematic review and meta-analysis ER Haut, LJ Garcia, HM Shihab, DJ Brotman, KA Stevens, R Sharma, ... JAMA surgery 149 (2), 194-202, 2014 | 173 | 2014 |
| Comparative study of the development of diabetes mellitus in patients taking risperidone and olanzapine MA Fuller, KM Shermock, M Secic, AL Grogg Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 23 (8 …, 2003 | 134 | 2003 |
| Change in reported adherence to nonpharmaceutical interventions during the COVID-19 pandemic, April-November 2020 MA Crane, KM Shermock, SB Omer, JA Romley Jama 325 (9), 883-885, 2021 | 124 | 2021 |
| Impact of a venous thromboembolism prophylaxis “smart order set”: improved compliance, fewer events AM Zeidan, MB Streiff, BD Lau, SR Ahmed, PS Kraus, DB Hobson, ... American journal of hematology 88 (7), 545-549, 2013 | 111 | 2013 |
| Activated partial thromboplastin time and anti-xa measurements in heparin monitoring: biochemical basis for discordance CM Takemoto, MB Streiff, KM Shermock, PS Kraus, J Chen, J Jani, ... American journal of clinical pathology 139 (4), 450-456, 2013 | 97 | 2013 |
| Patterns of non-administration of ordered doses of venous thromboembolism prophylaxis: implications for novel intervention strategies KM Shermock, BD Lau, ER Haut, DB Hobson, VS Ganetsky, PS Kraus, ... PloS one 8 (6), e66311, 2013 | 89 | 2013 |
| Cost-effectiveness analysis of augmentation therapy for severe α1-antitrypsin deficiency TR Gildea, KM Shermock, ME Singer, JK Stoller American journal of respiratory and critical care medicine 167 (10), 1387-1392, 2003 | 85 | 2003 |
| The use of lacosamide in refractory status epilepticus H Goodwin, HE Hinson, KM Shermock, N Karanjia, JJ Lewin Neurocritical care 14, 348-353, 2011 | 77 | 2011 |
| Clinical outcomes of patients with diabetes mellitus receiving medication management by pharmacists in an urban private physician practice NT Nkansah, JM Brewer, R Connors, KM Shermock American Journal of Health-System Pharmacy 65 (2), 145-149, 2008 | 66 | 2008 |
| Pharmacologic and mechanical strategies for preventing venous thromboembolism after bariatric surgery: a systematic review and meta-analysis DJ Brotman, HM Shihab, KR Prakasa, S Kebede, ER Haut, R Sharma, ... JAMA surgery 148 (7), 675-686, 2013 | 64 | 2013 |
| Number needed to treat and cost of recombinant human erythropoietin to avoid one transfusion-related adverse event in critically ill patients KM Shermock, E Horn, PA Lipsett, PJ Pronovost, T Dorman Critical care medicine 33 (3), 497-503, 2005 | 61 | 2005 |
| Validation and psychometric properties of the 8-item Morisky Medication Adherence Scale (MMAS-8) in Type 2 diabetes patients in sub-Saharan Africa S Tandon, M Chew, CK Eklu-Gadegbeku, KM Shermock, DE Morisky Diabetes research and clinical practice 110 (2), 129-136, 2015 | 56 | 2015 |
| Topical triple-antibiotic ointment as a novel therapeutic choice in wound management and infection prevention: a practical perspective RA Bonomo, PS Van Zile, Q Li, KM Shermock, WG McCormick, B Kohut Expert review of anti-infective therapy 5 (5), 773-782, 2007 | 56 | 2007 |
| Patient preferences for receiving education on venous thromboembolism prevention–a survey of stakeholder organizations VO Popoola, BD Lau, HM Shihab, NE Farrow, DL Shaffer, DB Hobson, ... PLoS One 11 (3), e0152084, 2016 | 51 | 2016 |
| Streamlining the process for initial review of pharmacy residency applications: an analytic approach CR Ensor, CL Walker, SK Rider, EU Clemente, DM Ashby, KM Shermock American Journal of Health-System Pharmacy 70 (19), 1670-1675, 2013 | 49 | 2013 |
| Identifying high-alert medications in a university hospital by applying data from the medication error reporting system L Tyynismaa, A Honkala, M Airaksinen, K Shermock, L Lehtonen Journal of patient safety 17 (6), 417-424, 2021 | 44 | 2021 |